RNRong Niu

Rong Niu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rong Niu has a total of 24 co-authors. Here are the top co-authors by number of shared publications:

  • Jinbao Feng

    Department of Nuclear Medicine, Changzhou Key Laboratory of Molecular Imaging, The Third Affiliated Hospital of Soochow University, The First People′s Hospital of Changzhou, Institute of Clinical Translation of Nuclear Medicine and Molecular Imaging, Soochow University

    4 shared publications
  • Yunmei Shi

    Department of Nuclear Medicine, Changzhou Key Laboratory of Molecular Imaging, The Third Affiliated Hospital of Soochow University, The First People′s Hospital of Changzhou, Institute of Clinical Translation of Nuclear Medicine and Molecular Imaging, Soochow University

    4 shared publications
  • Jianxiong Gao

    Department of Nuclear Medicine, Changzhou Key Laboratory of Molecular Imaging, The Third Affiliated Hospital of Soochow University, The First People′s Hospital of Changzhou, Institute of Clinical Translation of Nuclear Medicine and Molecular Imaging, Soochow University

    3 shared publications
  • Xiaonan Shao

    Department of Nuclear Medicine, Changzhou Key Laboratory of Molecular Imaging, The Third Affiliated Hospital of Soochow University, The First People′s Hospital of Changzhou, Institute of Clinical Translation of Nuclear Medicine and Molecular Imaging, Soochow University

    3 shared publications
  • Yan Sun

    Department of Nuclear Medicine, Changzhou Key Laboratory of Molecular Imaging, The Third Affiliated Hospital of Soochow University, The First People′s Hospital of Changzhou, Institute of Clinical Translation of Nuclear Medicine and Molecular Imaging, Soochow University

    3 shared publications
  • Mengyue Hu

    Department of Nuclear Medicine, Changzhou Key Laboratory of Molecular Imaging, The Third Affiliated Hospital of Soochow University, The First People′s Hospital of Changzhou, Institute of Clinical Translation of Nuclear Medicine and Molecular Imaging, Soochow University

    2 shared publications

Latest Publications

  • Open Access

    Imaging features of lung cancer with cystic airspaces: clinical utility, challenges, and perspectives

    by Mengyue Hu, Jinbao Feng, Xiaonan Shao, Yunmei Shi, Jianxiong Gao, Yaoting Zhu, Yuhao Fan, Yan Sun, Zhenxing Jiang, Rong Niu, et al.

    Lung cancer is a leading cause of cancer-related deaths worldwide and poses a significant health burden. Early diagnosis is critical for reducing lung cancer mortality. Lung Cancer with Cystic Airspaces (LCCA) is a distinct morphological subtype of lung cancer, characterized on imaging by cystic regions accompanied by solid components and/or ground-glass opacities. LCCA is relatively rare, with an incompletely understood pathogenesis, marked heterogeneity, and complex imaging manifestations. It accounts for approximately one-quarter of lung cancer cases that are missed or diagnosed late. With the widespread implementation of lung cancer screening, the detection rate of LCCA is increasing and has drawn growing attention. However, current research is limited by small sample sizes and predominantly retrospective study designs, posing significant clinical challenges in LCCA management. This article reviews the definition and underlying mechanisms of LCCA, systematically summarizes the clinical value of noninvasive imaging in diagnosis, classification, invasiveness prediction, staging, and prognosis assessment of LCCA, and discusses the limitations of existing studies as well as future research directions and challenges. The goal is to provide a theoretical basis for optimizing early lung cancer screening pathways and developing individualized intervention strategies, which holds important clinical significance for reducing lung cancer-related mortality.


  • Open Access

    Nonlinear association between standardized uptake value (SUV) index based on 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) and the new International Association for the Study of Lung Cancer (IASLC) grading of lung invasive non-mucinous adenocarcinoma

    by Jinbao Feng, Mengyue Hu, Xiaonan Shao, Jianxiong Gao, Yan Sun, Yaoting Zhu, Yuhao Fan, Yunmei Shi, Rong Niu

    Background: The new grading system for lung invasive non-mucinous adenocarcinoma (INMA) was proposed by the Pathology Committee of the International Association for the Study of Lung Cancer (IASLC) in 2020. Accurate identification of IASLC grading is crucial for the precise diagnosis, treatment, and prognosis evaluation of lung INMA. We aimed to investigate the association between standardized uptake value (SUV) index, defined as tumor maximum standardized uptake value (SUVmax) normalized by hepatic SUVmean, based on 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) and the new grading system for lung INMA proposed by IASLC. Methods: This retrospective study analyzed clinical and imaging data from 782 patients diagnosed with lung INMA via postoperative pathology who underwent preoperative 18F-FDG PET/CT between January 2018 and June 2023. Univariable and multivariable logistic regression analyses were performed to evaluate the independent association between SUV index and IASLC grading. Generalized additive models (GAMs) and smoothed spline curves were used to explore the shape of the relationship, and segmented regression models were applied to interpret nonlinearity. Results: Among all cases, 578 (73.9%) were classified as Grades 1–2, and 204 (26.1%) as Grade 3 according to the IASLC grading system. Multivariable logistic regression adjusted for relevant clinical and imaging covariates revealed that the SUV index was independently associated with an increased risk of Grade 3 lung INMA [odds ratio (OR) =2.086, 95% confidence interval (CI): 1.728–2.517, P=0.972). SUV index was an independent predictor of IASLC grading in lung INMA. Conclusions: A higher SUV index was associated with an increased risk of Grade 3 disease, following a nonlinear, S-shaped trend.

  • Open Access

    Application and progress of non-invasive imaging in predicting lung invasive non-mucinous adenocarcinoma under the new IASLC grading guidelines

    by Jinbao Feng, Xiaonan Shao, Jianxiong Gao, Xinyu Ge, Yan Sun, Yunmei Shi, Yuetao Wang, Rong Niu

    Lung cancer is the leading cause of cancer-related deaths worldwide, with invasive non-mucinous adenocarcinoma (INMA) being the most common type and carrying a poor prognosis. In 2020, the International Association for the Study of Lung Cancer (IASLC) pathology committee proposed a new histological grading system, which offers more precise prognostic assessments by combining the proportions of major and high-grade histological patterns. Accurate identification of lung INMA grading is crucial for clinical diagnosis, treatment planning, and prognosis evaluation. Currently, non-invasive imaging methods (such as CT, PET/CT, and MRI) are increasingly being studied to predict the new grading of lung INMA, showing promising application prospects. This review outlines the establishment and prognostic efficiency of the new IASLC grading system, highlights the application and latest progress of non-invasive imaging techniques in predicting lung INMA grading, and discusses their role in personalized treatment of lung INMA and future research directions. Critical relevance statement: The new IASLC grading system has important prognostic implications for patients with lung invasive non-mucinous adenocarcinoma (INMA), and non-invasive imaging methods can be used to predict it, thereby improving patient prognoses. Key Points: The new IASLC grading system more accurately prognosticates for patients with lung INMA. Preoperative prediction of the new grading is challenging because of the complexity of INMA subtypes. It is feasible to apply non-invasive imaging methods to predict the new IASLC grading system. Graphical


  • Open Access

    Primary mediastinal extraskeletal osteosarcoma on 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT): a case description

    by Zhimin Yang, Jianfeng Wang, Jinbao Feng, Yunmei Shi, Yuetao Wang, Rong Niu

    Primary mediastinal extraskeletal osteosarcoma on 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT): a case description

  • Open Access

    Association Analysis of Maximum Standardized Uptake Values Based on 18F-FDG PET/CT and EGFR Mutation Status in Lung Adenocarcinoma

    by Jianxiong Gao, Yunmei Shi, Rong Niu, Xiaoliang Shao, Xiaonan Shao

    (1) Background: To investigate the association between maximum standardized uptake value (SUVmax) based on 18F-FDG PET/CT and EGFR mutation status in lung adenocarcinoma. (2) Methods: A total of 366 patients were retrospectively collected and divided into the EGFR mutation group (n = 228) and EGFR wild-type group (n = 138) according to their EGFR mutation status. The two groups’ general information and PET/CT imaging parameters were compared. A hierarchical binary logistic regression model was used to assess the interaction effect on the relationship between SUVmax and EGFR mutation in different subgroups. Univariate and multivariate logistic regression was used to analyze the association between SUVmax and EGFR mutation. After adjusting for confounding factors, a generalized additive model and smooth curve fitting were applied to address possible non-linearities. (3) Results: Smoking status significantly affected the relationship between SUVmax and EGFR mutation (p for interaction = 0.012), with an interaction effect. After adjusting for age, gender, nodule type, bronchial sign, and CEA grouping, in the smoking subgroup, curve fitting results showed that the relationship between SUVmax and EGFR mutation was approximately linear (df = 1.000, c2 = 3.897, p = 0.048); with the increase in SUVmax, the probability of EGFR mutation gradually decreased, and the OR value was 0.952 (95%CI: 0.908–0.999; p = 0.045). (4) Conclusions: Smoking status can affect the relationship between SUVmax and EGFR mutation status in lung adenocarcinoma, especially in the positive smoking history subgroup. Fully understanding the effect of smoking status will help to improve the accuracy of SUVmax in predicting EGFR mutations.


  • Radiomics model based on preoperative 18F-fluorodeoxyglucose PET predicts N2-3b lymph node metastasis in gastric cancer patients

    by Xiu-Qing Xue, Wen-Ji Yu, Xiao-Liang Shao, Xiao-Feng Li, Rong Niu, Fei-Fei Zhang, Yun-Mei Shi, Yue-Tao Wang

    Objective: The aim of the study was to construct and validate 18F-fluorodeoxyglucose (18F-FDG) PET-based radiomics nomogram and use it to predict N2-3b lymph node metastasis in Chinese patients with gastric cancer (GC). Methods: A total of 127 patients with pathologically confirmed GC who underwent preoperative 18F-FDG PET/CT imaging between January 2014 and September 2020 were enrolled as subjects in this study. We use the LIFEx software to extract PET radiomic features. A radiomics signature (Rad-score) was developed with the least absolute shrinkage and selection operator algorithm. Then a prediction model, which incorporated the Rad-score and independent clinical risk factors, was constructed and presented with a radiomics nomogram. Receiver operating characteristic (ROC) analysis was used to assess the performance of Rad-score and the nomogram. Finally, decision curve analysis (DCA) was applied to evaluate the clinical usefulness of the nomogram. Results: The PET Rad-score, which includes four selected features, was significantly related to pN2-3b (all P < 0.05). The prediction model, which comprised the Rad-score and carcinoembryonic antigen (CEA) level, showed good calibration and discrimination [area under the ROC curve: 0.81(95% confidence interval: 0.74–0.89), P < 0.001)]. The DCA also indicated that the prediction model was clinically useful. Conclusion: This study presents a radiomics nomogram consisting of a radiomics signature based on PET images and CEA level that can be conveniently used for personalized prediction of high-risk N2-3b metastasis in Chinese GC patients.